Cargando…
Prevalence of Neutralising Antibodies to HCoV-NL63 in Healthy Adults in Australia
The COVID-19 pandemic has highlighted the importance of understanding the immune response to seasonal human coronavirus (HCoV) infections such as HCoV-NL63, how existing neutralising antibodies to HCoV may modulate responses to SARS-CoV-2 infection, and the utility of seasonal HCoV as human challeng...
Autores principales: | Lynch, Sean A., Subbarao, Kanta, Mahanty, Siddhartha, Barber, Bridget E., Roulis, Eileen V., van der Hoek, Lia, McCarthy, James S., Spann, Kirsten M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402802/ https://www.ncbi.nlm.nih.gov/pubmed/34452482 http://dx.doi.org/10.3390/v13081618 |
Ejemplares similares
-
Seroconversion to HCoV-NL63 in Rhesus Macaques
por: Dijkman, Ronald, et al.
Publicado: (2009) -
Understanding Human Coronavirus HCoV-NL63
por: Abdul-Rasool, Sahar, et al.
Publicado: (2010) -
Novel polymeric inhibitors of HCoV-NL63
por: Milewska, Aleksandra, et al.
Publicado: (2013) -
Inhibition of HCoV-NL63 infection at early stages of the replication cycle
por: van der Hoek, L., et al.
Publicado: (2006) -
Human Coronaviruses HCoV-NL63 and HCoV-HKU1 in Hospitalized Children with Acute Respiratory Infections in Beijing, China
por: Cui, Li-Jin, et al.
Publicado: (2011)